- Sign the EU Manifesto on Influenza Vaccination
- On March 12, EFA launched a 10-point Manifesto calling the EU for more action to increase seasonal influenza vaccination coverage rates in Europe. Influenza is annually responsible for 650 thousand de ...
- Patients’ safety and public health post-Brexit
- On the 21st of February, EFA Director of Policy and Strategy Roberta Savli participated in an event organised by a broad coalition of public health actors on the need to prioritise patients’ safety ...
- EFA Patients at BBMRI-ERIC Stakeholder Forum
- EFA's Roberta Savli participated on the 25th of January in the Stakeholder Forum meeting of the BBMRI-ERIC. The meeting served to identify the priorities of action and to organize and agree on the wor ...
- Amsterdam will be the European city for the evaluation of medicines
- The European Medicines Agency (EMA) will move from London to Amsterdam (The Netherlands) by March 2019. The EMA is the EU agency in charge of medicines evaluation and safety monitoring. The relo ...
- Patients organisations, their added value and importance in decision-making
- In November, the European Patients’ Forum (EPF) published the report gathering key insights and opinions from the European patients’ movement, including EFA’s, demonstrating the added-value through th ...
- Digital Health becomes a priority for the European Medicines Agency
- In October the European Medicines Agency launched a new topic group on digital health that will provide insights and recommendations to the agency on how to tackle the digital dimension of medicines a ...
- Patients and healthcare professionals discussed our role in antimicrobial resistance at the EMA
- EFA Vice President Erna Botjes attended three important meetings at the European Medicines Agency: a workshop on antimicrobial resistance, the joint and regular meeting of patients and healthcare prof ...
- New updates on U-BIOPRED, supported by EFA
- The U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) outcomes, in which EFA contributed, have been summarised in an interview published by European Respiratory & Pulmo ...
- EFA at the leading respiratory (ERS) and dermatology (EADV) conferences
- EFA will participate this September in two leading respiratory and dermatology conferences, where we will expose our projects and bring our patients perspective to those fields. From the 9 to 13 ...
- EFA brought the patient perspective to the Bavarian State Ministers for Health and Care panel discussion
- EFA’s Susanna Palkonen represented the patient view for us and the European Patients' Forum in a panel discussion “The access to medicines – Challenges and perspectives for Europe” hosted by the Bavar ...
- More Europe for better innovation for health and wellbeing
- Europe is in an ideal position to take the leading role health and wellbeing’ according to the new editorial of Progress and Preventive Medicine “Viva Europa, a land of excellence in research and inno ...
- EFA 2020 - The future of allergy, asthma and COPD patients Europe
- Updating and upgrading EFA priorities 2020. AGM, Florence, 22May 2017 Stanimir Hasurdjiev, Patient Access Partnership PACT and European Patient’s Forum representative presented on patient involvemen ...
- MyAirCoach presented at eHealth Week
- New technologies can revolutionise the healthcare system, providing a better delivery of services and developing effective health policy. We are now able to access and share personal health data, thus ...
- United Action for Allergy and Asthma
- A political Call to Action in Europe Allergy and asthma are among the most frequent chronic diseases in the European Union (EU). Over 150 million EU citizens – almost one in three people – suffer fr ...
- Patients and consumers remind on key requirements for the re-location of the European Medicines Agency
- On April 25th 14 Members of the Patients and Consumers Working Party (PCWP) of the European Medicines Agency (EMA) sent a letter the Health Commissioner, the President of the European Council and the ...
- The first EP event of the year put the focus on health: Act. Believe. Care.
- Chronic respiratory diseases need public policy solutions at European level to respond to increasing disease prevalence, unmet treatment needs, high cost of hospitalisations, work and school sick-leav ...
- IMI looks into what patients bring to medicines
- The Innovative Medicines Initiative launched in December its 10th call for proposals under IMI 2. We especially welcome one of the topics of this call: “Patient Perspectives in medicines lifecycle”. T ...
- First congress of allergy respiratory patients in Spain
- On the occasion of World COPD Day EFA Spanish Member FENAER, organized the First Congress of Allergy and Respiratory Patients in Madrid. During the event, FENAER presented the outcome of their latest ...
- PRESS RELEASE: Smartphones could improve young people’s health literacy and adherence
- 2016 European Health Forum Gastein (Austria) – Asthma is the most common chronic disease in childhood. Today, 30 million European children and adults below the age of 45 years old have asthma and 15,0 ...
- More research into earlier diagnosis – Our response to H2020 consultation
- During the summer, EFA had the chance to provide feedback on the development of the work programme 2018-2020 of Horizon 2020 (the European Union’s Research and Innovation Framework Programme) in respo ...